Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Messoud Ashina

Showing results (291-300 of 432) with videos related to

Pageof 44
Sort By:
European Journal of Neurology|November 13, 2023
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trialMessoud Ashina, Richard B Lipton, Jessica Ailani, et al.
European Journal of Neurology|March 16, 2026
Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have FailedJessica Ailani, Messoud Ashina, Susanne F Awad, et al.
Cephalalgia : an International Journal of Headache|April 17, 2013
The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteersFaisal Mohammad Amin, Mohammad Sohail Asghar, Julie W Ravneberg, et al.
Cephalalgia : an International Journal of Headache|March 20, 2016
Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraineSong Guo, Anne Luise Haulund Vollesen, Rikke Dyhr Hansen, et al.
JAMA Neurology|December 20, 2021
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical TrialsMessoud Ashina, Peter J Goadsby, David W Dodick, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 16, 2025
Association between serum high-sensitivity C-reactive protein levels and migraine: a REFORM studyBetel Tesfay, Håkan Ashina, William Kristian Karlsson, et al.
The Journal of Headache and Pain|June 20, 2018
Effects of sildenafil and calcitonin gene-related peptide on brainstem glutamate levels: a pharmacological proton magnetic resonance spectroscopy study at 3.0 TSamaira Younis, Anders Hougaard, Casper Emil Christensen, et al.
Cephalalgia : an International Journal of Headache|June 30, 2020
Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteersLanfranco Pellesi, Mohammad Al-Mahdi Al-Karagholi, Basit Ali Chaudhry, et al.
Pain Reports|February 4, 2026
Serum tumor necrosis factor-α levels in migraine: a registry for migraine (REFORM) studyBetel Tesfay, William K Karlsson, Håkan Ashina, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 20, 2020
Glutamate levels and perfusion in pons during migraine attacks: A 3T MRI study using proton spectroscopy and arterial spin labelingSamaira Younis, Casper E Christensen, Mark B Vestergaard, et al.
Pageof 44

Showing results (291-300 of 432) with videos related to

Sort By:
Pageof 44
European Journal of Neurology|November 13, 2023
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trialMessoud Ashina, Richard B Lipton, Jessica Ailani, et al.
European Journal of Neurology|March 16, 2026
Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have FailedJessica Ailani, Messoud Ashina, Susanne F Awad, et al.
Cephalalgia : an International Journal of Headache|April 17, 2013
The effect of sumatriptan on cephalic arteries: A 3T MR-angiography study in healthy volunteersFaisal Mohammad Amin, Mohammad Sohail Asghar, Julie W Ravneberg, et al.
Cephalalgia : an International Journal of Headache|March 20, 2016
Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraineSong Guo, Anne Luise Haulund Vollesen, Rikke Dyhr Hansen, et al.
JAMA Neurology|December 20, 2021
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical TrialsMessoud Ashina, Peter J Goadsby, David W Dodick, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 16, 2025
Association between serum high-sensitivity C-reactive protein levels and migraine: a REFORM studyBetel Tesfay, Håkan Ashina, William Kristian Karlsson, et al.
The Journal of Headache and Pain|June 20, 2018
Effects of sildenafil and calcitonin gene-related peptide on brainstem glutamate levels: a pharmacological proton magnetic resonance spectroscopy study at 3.0 TSamaira Younis, Anders Hougaard, Casper Emil Christensen, et al.
Cephalalgia : an International Journal of Headache|June 30, 2020
Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteersLanfranco Pellesi, Mohammad Al-Mahdi Al-Karagholi, Basit Ali Chaudhry, et al.
Pain Reports|February 4, 2026
Serum tumor necrosis factor-α levels in migraine: a registry for migraine (REFORM) studyBetel Tesfay, William K Karlsson, Håkan Ashina, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 20, 2020
Glutamate levels and perfusion in pons during migraine attacks: A 3T MRI study using proton spectroscopy and arterial spin labelingSamaira Younis, Casper E Christensen, Mark B Vestergaard, et al.
Pageof 44